CORRECTING and REPLACING Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Genprex, Inc. (GNPX)
Last genprex, inc. earnings: 11/14 12:08 pm
Check Earnings Report
Company Research
Source: Business Wire
AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Date, time and room of presentation of release dated September 5, 2019, should read: Monday, September 9, 2019, from 12:30-12:55 p.m. EDT in Adams (instead of Tuesday, September 10, 2019, from 3:00-3:25 p.m. EDT in Holmes I).The corrected release reads:GENPREX TO PRESENT AT THE H.C. WAINWRIGHT 21ST ANNUAL GLOBAL INVESTMENT CONFERENCEGenprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that it will present at the H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019 in New York City.Genprex’s Chairman and Chief Executive Officer, Rodney Varner, will lead the company's presentation and will be available for one-on-one meetings.Genprex will present at the H.C. Wainwright 21st Annual Global Investment Conference as follows:Date: Monday, September 9, 2019Time: 12:30-12:55 p.m. EDTVenue: Lotte New York Palace Hotel, New York CityRoom: Adams (4th Floor)Several networking opportuniti
Show less
Read more
Impact Snapshot
Event Time:
GNPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GNPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GNPX alerts
High impacting Genprex, Inc. news events
Weekly update
A roundup of the hottest topics
GNPX
News
- Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual MeetingPR Newswire
- Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up [Yahoo! Finance]Yahoo! Finance
- Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer [Yahoo! Finance]Yahoo! Finance
- Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung CancerPR Newswire
GNPX
Earnings
- 8/21/23 - Miss
GNPX
Sec Filings
- 4/17/24 - Form S-8
- 4/1/24 - Form 10-K
- 3/20/24 - Form 424B5
- GNPX's page on the SEC website